SLC35E2B: Glucose Transporter and Regulatory Protein (G728661)

Target Name: SLC35E2B

NCBI ID: G728661

SLC35E2B

SLC35E2B: Glucose Transporter and Regulatory Protein

SLC35E2B (Sodium-Glucose cotransporter 2B) is a protein that is expressed in various tissues and cells in the body. It is a member of the SLC family of transmembrane proteins, which are responsible for transporting various molecules across the cell membrane. SLC35E2B is specifically involved in the transport of glucose across the cell membrane, and is expressed in the endoplasmic reticulum (ER) and endosomal system (ES).

SLC35E2B is a 21-kDa protein that is composed of 216 amino acid residues. It has a calculated pI of around 120 nm and a calculated molecular weight of 21 kDa. SLC35E2B is expressed in a variety of tissues and cells, including the brain, heart, skeletal muscles, liver, and kidney. It is also expressed in various cell lines, including HeLa and PC12 cells.

SLC35E2B is involved in the transport of glucose across the cell membrane. It is a type of transmembrane protein that is involved in the production of the first new glucose transporter (SLC30A4) in the endoplasmic reticulum (ER). SLC30A4 is then translated and translated into the SLC35E2B protein. SLC35E2B is expressed in the ER and ES and is responsible for the high affinity transport of glucose across the cell membrane.

SLC35E2B is also involved in the regulation of glucose metabolism. It has been shown to be regulated by various enzymes, including GLUT1, GLUT2, and Insulin. SLC35E2B has been shown to be phosphorylated by GLUT1 and GLUT2, which are known to play important roles in the regulation of glucose metabolism.

SLC35E2B has also been shown to be involved in the regulation of inflammation. It has been shown to be regulated by various enzymes, including cyclophosphamide (Cp) and thymidine (Td). SLC35E2B has been shown to be phosphorylated by Cp and Td, which are known to play important roles in the regulation of inflammation.

SLC35E2B is also involved in the regulation of pain perception. It has been shown to be regulated by various enzymes, including capsaicin (Caps) and bradykinin (BK). SLC35E2B has been shown to be phosphorylated by Caps and BK, which are known to play important roles in the regulation of pain perception.

In conclusion, SLC35E2B is a protein that is involved in the transport of glucose across the cell membrane and in the regulation of glucose metabolism, inflammation, and pain perception. As a potential drug target, SLC35E2B may be useful in the development of various diseases, including diabetes, cancer, and pain perception. Further research is needed to fully understand the role of SLC35E2B in the regulation of glucose metabolism and to determine its potential as a drug target.

Protein Name: Solute Carrier Family 35 Member E2B

Functions: Putative transporter

The "SLC35E2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35E2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets